a month ago
ARWR
AnalystsBrian ChengBrian Cheng's Stock Forecasts
AnalystsBrian Cheng
Sectors:
Industries:
Analyst Ranking
Top 16%
#869 out of 5491 analysts
Average Return
+11.49%
Win Rate
49%45 out of 91
Risk vs Reward
Poor
Good
Brian Cheng's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +234.88% | $61.38 | $205.55 | 2025-11-06 - 2026-08-11 | Strong Buy |
Protagonist Therapeutics IncPTGX | +170.97% | $17.19 | $46.58 | 2023-09-25 - 2024-09-24 | Strong Buy |
Immunovant IncIMVT | +169.10% | $15.21 | $40.93 | 2025-08-12 - 2026-08-11 | Strong Buy |
Absci CorpABSI | +165.07% | $3.55 | $9.41 | 2025-10-02 - 2026-08-11 | Strong Buy |
Immunome IncIMNM | +161.60% | $9.87 | $25.82 | 2025-08-07 - 2026-08-06 | Strong Buy |
Brian Cheng Analyst Color
Get additional color on Brian Cheng's coverage of popular stocks
4 months ago
CGON
5 months ago
PTGX
Brian Cheng's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Monte Rosa Therapeutics IncGLUE | 2 | Strong Buy | $27.00 | +71.32% | Maintains | 5 days ago |
Tg Therapeutics IncTGTX | 2 | Strong Buy | $72.00 | +44.29% | Maintains | 5 days ago |
Odyssey Therapeutics IncODTX | 2 | Strong Buy | $29.00 | +42.51% | Maintains | 5 days ago |
Immunovant IncIMVT | 5 | Strong Buy | $50.00 | +22.16% | Maintains | 8 days ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | $10.00 | +39.28% | Initiates Coverage On | 19 days ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Strong Buy | $95.00 | +6.45% | Maintains | a month ago |
Tango Therapeutics IncTNGX | 1 | Strong Buy | $46.00 | +74.64% | Initiates Coverage On | a month ago |
Protara Therapeutics IncTARA | 2 | Strong Buy | $26.00 | +564.96% | Maintains | 3 months ago |
Kyverna Therapeutics IncKYTX | 3 | Strong Buy | $29.00 | +261.60% | Maintains | 3 months ago |
Cg Oncology IncCGON | 4 | Strong Buy | $96.00 | +24.63% | Maintains | 3 months ago |
Xencor IncXNCR | 7 | Hold | $14.00 | -36.65% | Maintains | 3 months ago |
Allogene Therapeutics IncALLO | 6 | Hold | N/A | N/A | Upgrades | 4 months ago |
Protagonist Therapeutics IncPTGX | 7 | Strong Buy | $106.00 | -28.52% | Maintains | 5 months ago |
Eikon Therapeutics IncEIKN | 1 | Strong Buy | $29.00 | +183.48% | Initiates Coverage On | 5 months ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $122.00 | -40.65% | Maintains | 6 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $125.00 | +14.03% | Maintains | 8 months ago |
Opko Health IncOPK | 1 | Hold | N/A | N/A | Initiates Coverage On | 9 months ago |
Intellia Therapeutics IncNTLA | 5 | Strong Sell | $5.00 | -58.40% | Downgrades | 9 months ago |
Zymeworks IncZYME | 3 | Strong Buy | $23.00 | -5.43% | Maintains | 10 months ago |
Pliant Therapeutics IncPLRX | 1 | Strong Sell | N/A | N/A | Downgrades | 10 months ago |
Absci CorpABSI | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 10 months ago |
Roivant Sciences LtdROIV | 7 | Strong Buy | $20.00 | -43.26% | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $70.00 | +29.46% | Initiates Coverage On | a year ago |
Precigen IncPGEN | 3 | Hold | N/A | N/A | Upgrades | a year ago |
Immunome IncIMNM | 3 | Strong Buy | $22.00 | N/A | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 3 | Hold | $129.00 | N/A | Downgrades | a year ago |
Iteos Therapeutics IncITOS | 4 | Hold | $8.00 | N/A | Downgrades | a year ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a year ago |
Cargo Therapeutics IncCRGX | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Editas Medicine IncEDIT | 3 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Metagenomi Therapeutics IncMGX | 2 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Mersana Therapeutics IncMRSN | 3 | Hold | $125.00 | N/A | Upgrades | 2 years ago |
Bioatla IncBCAB | 3 | Strong Buy | $700.00 | N/A | Maintains | 3 years ago |
Adc Therapeutics SaADCT | 3 | Hold | N/A | N/A | Upgrades | 3 years ago |
Adicet Bio IncACET | 2 | Hold | $96.00 | N/A | Downgrades | 3 years ago |
Senti Biosciences Holdings IncSNTI | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Gossamer Bio IncGOSS | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Clovis Oncology IncCLVSQ | 1 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Sierra Oncology IncSRRA | 2 | Strong Buy | $39.00 | N/A | Maintains | 5 years ago |
Regulus Therapeutics IncRGLS | 2 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Strong Buy | $85.00 | N/A | Maintains | 5 years ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.